Chromosome 22 open reading frame 15, known as C22orf15, is a gene that is situated on the 22nd chromosome in humans. The term "open reading frame" refers to a segment of the genome that has the potential to be translated into a protein. C22orf15 is designated as such because it has been identified through bioinformatic analyses and is believed to encode for a protein, but its specific biological function and significance might not be well characterized.The protein product of C22orf15 is presumed to have a distinct role within cells, which could range from participating in cellular structure and integrity to functioning in signal transduction, metabolic processes, or gene regulation. However, the lack of detailed information about the gene product means that the function of the C22orf15 protein is still under investigation.
Additionally, studying the protein's localization within the cell can help deduce its potential interactions and roles.Analysis of the protein structure, including the presence of specific domains or motifs, can suggest possible molecular functions or interactions with other proteins or nucleic acids. Experimental approaches like gene silencing or knockout studies in model organisms or cellular systems might be used to determine what happens in the absence of the C22orf15 protein, providing insights into its biological importance.In essence, C22orf15 represents a genomic entity on chromosome 22 that is thought to code for a protein, the exact functions of which are yet to be fully understood. Genes like C22orf15 are often subjects of ongoing research, contributing to our broader understanding of cellular mechanisms and the complex network of genetic instructions that are crucial for life.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
This compound intercalates into DNA, blocking transcription and thus could inhibit C22orf15 expression by blocking mRNA synthesis. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
By inhibiting eukaryotic protein synthesis, this compound could indirectly suppress C22orf15 expression by reducing overall protein levels. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
This toxin inhibits RNA polymerase II, potentially reducing C22orf15 mRNA transcription and subsequent protein expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
As an mTOR inhibitor, rapamycin can downregulate protein synthesis, which may indirectly decrease C22orf15 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
This proteasome inhibitor can cause the accumulation of misfolded proteins, potentially affecting C22orf15 expression through cellular stress responses. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By causing DNA demethylation, this compound can alter gene expression patterns, possibly reducing the expression of C22orf15. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
As a histone deacetylase inhibitor, it can modify chromatin structure and potentially downregulate C22orf15 expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine inhibits lysosomal activity, which may affect C22orf15 expression indirectly through altered cellular degradation pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
This metabolite of vitamin A can regulate gene expression, which might include the downregulation of C22orf15 protein levels. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
This PI3K inhibitor can affect the AKT signaling pathway, potentially leading to reduced expression of certain proteins, which may include C22orf15. |